AusDiagnostics has opened a new state-of-the-art production facility in Sydney, alongside the launch of
their new Puryx™ extraction kit product line.
The Puryx™ product line encompasses kits that extract pathogen derived nucleic acids from patient samples to prepare them for subsequent laboratory detection of infections and other pathogens, including testing for COVID-19.
In response to the global shortage of necessary reagents and kits to adequately address COVID-19
testing, AusDiagnostics partnered with the Federal Government in June to pledge the creation of the new facility to meet the current and future demands.